Global Transcatheter Mitral Valve Repair and Replacement Market Overview:
Mitral valve regurgitation belongs to one of the most common acquired valve diseases in western countries with increasing prevalence in older age. This market emerges as an alternative for the mitral regurgitation majorly for patients are having huge surgical risks. Some of the players profiled in the study are Edwards Lifesciences (United States), Medtronic Plc (Ireland), Abbott Laboratories (United States), Neovasc Inc. (Canada), Cardiac Dimensions Inc. (United States), Colibri Heart Valve LLC (United States), HLT, Inc. (United States), LivaNova Plc (United Kingdom), Neovasc Inc. (Canada) and NeoChord (United States).
On the basis of geography, the market of Transcatheter Mitral Valve Repair and Replacement has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Products, the sub-segment i.e. Mechanical Valves will boost the Transcatheter Mitral Valve Repair and Replacement market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Indications, the sub-segment i.e. Mitral Valve Stenosis will boost the Transcatheter Mitral Valve Repair and Replacement market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Rise in Occurrence Mitral Valve Regurgitation
- Increase in Awareness Among End Customers
- Increase in Investment in Research and Development
- The Surge in Market Competencies
- The Slowdown in Economy Because of Coronavirus Pandemic
- Increasing Number of New Market Players
- Technology Development
- High Cost Associated with Transcatheter Mitral Valve Repair and Replacement
Key Market Developments:
In Sep 2019, Medtronic announced the approval of its feasibility study for its Intrepid transcatheter mitral valve replacement system by the FDA. This will come up as a transfemoral approach for mitral valve replacement. Through this initiative, the company is aiming to capture market growth opportunities in the coming years.
The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing on the production technologies, efficiency enhancement, and product life. There is numerous growth opportunity in this market, with rising surgical risk. These opportunities are captured by leading players via tracking the ongoing process enhancement and enormous investment in market growth strategies.
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Transcatheter Mitral Valve Repair and Replacement Providers, Government Regulatory and Research Organizations and End-Use Industries
Major Objectives Focused through this Study
To define, describe, and forecast the Global Transcatheter Mitral Valve Repair and Replacement market on the basis of product [Transcatheter Mitral Valve Repair and Transcatheter Mitral Valve Replacement] , application [Hospitals, Clinics and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Transcatheter Mitral Valve Repair and Replacement market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Transcatheter Mitral Valve Repair and Replacement industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Venus Medtech (China) and Transcatheter Technologies GmbH (Germany).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Transcatheter Mitral Valve Repair and Replacement market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.